Suchergebnisse - "Nilsson, Monique B"

PubPharm (6)

1

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

enthalten in: Cancer cell | 2024

von Heeke, S. | Gay, C. | Estecio, M. | +39

2

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

enthalten in: Cancer cell | 2023

von Nilsson, M. | Yang, Y. | Heeke, S. | +24

3

Poziotinib for EGFR exon 20-mutant NSCLC : Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

enthalten in: Cancer cell | 2022

von Elamin, Y. | Robichaux, J. | Carter, B. | +24

CommentIn: Cancer Cell. 2022 Jul 11;40(7):705-708. - PMID 35820394

4

ARTEMIS highlights VEGF inhibitors as effective partners for EGFR TKIs in EGFR mutant NSCLC

enthalten in: Cancer cell | 2021

von Le, X. | Nilsson, M. | Robichaux, J. | +1

CommentOn: Cancer Cell. 2021 Sep 13;39(9):1279-1291.e3. - PMID 34388377

5

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

enthalten in: Cancer cell | 2020

von Robichaux, J. | Elamin, Y. | Vijayan, R. | +28

ErratumFor: Cancer Cell. 2019 Oct 14;36(4):444-457.e7. - PMID 31588020

6

Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity

enthalten in: Cancer cell | 2019

von Robichaux, J. | Elamin, Y. | Vijayan, R. | +28

ErratumIn: Cancer Cell. 2020 Mar 16;37(3):420. - PMID 32183953

1
[1]